LGALS3 and cancer: Interestingly, galectin-3-mediated cell proliferation, migration and invasion was reduced by treatment with DKK1, which suggested that the upregulation of WNT-1 expression by galectin-3 may play an important role in Wnt/β-catenin pathway activation in galectin-3-positive cancer cells [112].